“verastem” Archives

in
Entry Author Date Location
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
Westphal’s Flex Pharma To Cut Jobs and Seek Sale After Clinical Flop 06/13/18 Boston
Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More 02/09/18 National
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA 02/07/18 Boston
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 06/17/16 National
With CRISPR in Humans On The Horizon, Will the Public Back Intellia? 04/29/16 Boston
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
Verastem Sinks as Mesothelioma Study Halted For Futility 09/28/15 Boston
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More 08/28/15 New York
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M 09/09/14 Boston
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
East Coast Life Sciences Roundup: Alkermes, Ensemble, Sinai, & More 07/19/13 Boston
OncoMed Pharmaceuticals Soars in IPO Debut 07/18/13 San Francisco
East Coast Life Sciences Roundup: ASCO, Follica, Aveo, & More 06/07/13 Boston
Verastem Switches CEOs as Westphal Steps Into Chairman Role 06/06/13 Boston
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
GlaxoSmithKline Shuts Down Sirtris, Five Years After $720M Buyout 03/12/13 Boston
Radius Fourth Boston-area Biotech This Year Going for IPO 10/24/12 Boston
Biotech IPOs Start to Show Some Modest Signs of Life 04/30/12 National
Page 1 of 2 next page »